Bengaluru – Corona Remedies Limited, a ChrysCapital-backed branded pharmaceutical company, has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise up to ₹800 crore through an Offer for Sale (OFS).
The company develops and markets products across women’s health, cardio-diabetes, pain management, urology, and other therapeutic areas.
The equity shares will be listed on the BSE and NSE.
JM Financial, IIFL Capital Services, and Kotak Mahindra Capital are the Book Running Lead Managers.
